Harmony Biosciences Holdings Inc share price logo

Harmony Biosciences Holdings Inc Share Price

NASDAQ: HRMY

Mid Cap

$32.51

+0.12

(+0.36%)

as on

Harmony Biosciences Holdings Inc Stock Performance

as on September 16, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $31.61
    $32.58
    downward going graph

    2.77%

    Downside

    0.22%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $26.47
    $41.61
    downward going graph

    18.58%

    Downside

    27.99%

    Upside

    downward going graph

Harmony Biosciences Holdings Inc share price movements today

Previous Close
$32.39
Open
$32.21
Volume
631.2K
Day's Low - High
$31.61 - $32.58
52 Week Low - High
$26.47 - $41.61

Harmony Biosciences Holdings Inc Historical Returns

1 Month Return
-12.15 %
3 Month Return
-1.76 %
1 Year Return
-16.76 %
3 Year Return
-27.93 %
5 Year Return
-9.02 %

Harmony Biosciences Holdings Inc Stock Fundamentals & Key Indicators

Check Harmony Biosciences Holdings Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.9B

EPS (TTM)

3.9585

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

2.40%

PE Ratio (TTM)

10.45

Industry PE ratio

10.127857142857144

P/B Ratio

10.4484

PEG Ratio

0

EBITDA

245.7M

Revenue (TTM)

772.5M

Profit Margin

23.42%

Return On Equity TTM

27.58%

Harmony Biosciences Holdings Inc Stock Valuation

Track how Harmony Biosciences Holdings Inc P/E has moved over time to understand its valuation trends.

Harmony Biosciences Holdings Inc in the last 5 years

  • Overview

  • Trends

Lowest (9.01x)

June 30, 2025

Industry (10.13x)

September 15, 2025

Today (10.45x)

September 15, 2025

Highest (48.02x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: 10.45x

Harmony Biosciences Holdings Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Harmony Biosciences Holdings Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$1.9B-9.02%10.4523.42%
BUY$61.1B256.98%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$101.1B47.85%28.0731.86%
BUY$59.4B-3.43%14.1131.37%

Stock Returns calculator for Harmony Biosciences Holdings Inc Stock including INR - Dollar returns

The Harmony Biosciences Holdings Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Harmony Biosciences Holdings Inc investment value today

Current value as on today

₹88,537

Returns

₹11,463

(-11.46%)

Returns from Harmony Biosciences Holdings Inc Stock

₹16,448 (-16.45%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Harmony Biosciences Holdings Inc Stock

Based on 14 analysts

BUY

78.57%

Buy

7.14%

Hold

14.29%

Sell

Based on 14 analysts, 78.57% of analysts recommend a 'BUY' rating for Harmony Biosciences Holdings Inc. Average target price of $50.64

Harmony Biosciences Holdings Inc Share Price Target

Get share price movements and forecasts by analysts on Harmony Biosciences Holdings Inc.

What analysts predicted

35.8%UPSIDE

Target Price

$50.64

Current Price

$32.51

Analyzed by

14 Analysts

Target

$50.64

Harmony Biosciences Holdings Inc target price $50.64, a slight upside of 35.8% compared to current price of $32.51. According to 14 analysts rating.

Harmony Biosciences Holdings Inc Stock's Interest Amongst Investors

Search interest for Harmony Biosciences Holdings Inc Stock has increased by 27% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:27% versus previous 30 day period

Harmony Biosciences Holdings Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
119
134
160
168
154
172
186
201
184
200
Gross Profit
98
109
127
125
121
134
143
146
152
162
Operating Income
40
46
64
40
52
21
61
55
56
48
EBITDA
46
52
70
46
58
27
72
66
66
59
Interest Expense
5
6
7
4
4
4
4
4
3
3
Depreciation
6
6
6
6
6
6
5
5
5
5
Income Before Tax
37
44
51
39
51
21
62
56
57
49
Income Tax Expense
8
9
13
13
13
10
16
6
-11
9
Net Income
29
34
38
26
38
11
46
49
45
39
Net Profit Margin
24.75%
25.56%
24.00%
15.80%
24.79%
6.71%
24.78%
24.58%
24.66%
19.84%

Harmony Biosciences Holdings Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
5
159
305
437
582
714
Gross Profit
0
4
132
249
354
460
557
Operating Income
-41
-145
3
68
120
192
190
EBITDA
-41
-142
1
106
143
221
233
Interest Expense
-
6
28
23
18
23
17
Depreciation
0
3
10
18
23
24
24
Income Before Tax
-39
-151
-36
37
104
173
191
Income Tax Expense
1
6
14
2
-76
44
46
Net Income
-39
-158
-51
34
181
128
145
Net Profit Margin
0.00%
-2636.36%
-32.46%
11.33%
41.44%
22.14%
20.36%

Harmony Biosciences Holdings Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
34
38
26
38
11
46
49
45
39
Operating Cash Flow
37
63
76
31
42
70
75
33
79
Investing Cash Flow
-7
0
-36
-6
-54
0
-7
2
-19
Financing Cash Flow
0
-55
-53
-3
-3
-1
-2
0
-2
Change in Cash
28
7
-12
21
-15
70
65
35
57

Harmony Biosciences Holdings Inc Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-151
-36
34
181
128
145
Operating Cash Flow
-75
-2
98
144
219
219
Investing Cash Flow
-127
-2
-100
-141
-46
-67
Financing Cash Flow
143
209
7
6
-105
-10
Change in Cash
-58
204
5
9
67
141

Global Institutional Holdings in Harmony Biosciences Holdings Inc

Funds
Holdings
Valor Management LLC
11.5%
BlackRock Inc
11.32%
FMR Inc
9.29%
Vanguard Group Inc
8.17%
State Street Corp
2.74%

Insights on Harmony Biosciences Holdings Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 184.73M → 200.48M (in $), with an average increase of 7.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 142.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 86.8%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 49.47M → 39.77M (in $), with an average decrease of 10.3% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, HRMY stock has moved down by -11.9%

About Harmony Biosciences Holdings Inc

patients are at the beginning, middle, and heart of all we do. harmony biosciences, llc, is a privately-owned biopharmaceutical company. the company was established in october 2017 with a vision to provide novel treatment options for people living with rare and orphan diseases with an emphasis on central nervous system disorders, starting with a focus on helping patients who live with narcolepsy. harmony biosciences is committed to advancing the understanding of narcolepsy and providing information and resources to individuals who live with, and healthcare professionals who treat, patients with narcolepsy.
OrganisationHarmony Biosciences Holdings Inc
Headquarters630 West Germantown Pike, Plymouth Meeting, PA, United States, 19462
IndustryHealth Technology
CEODr. Jeffrey M. Dayno M.D.
E-voting on sharesClick here to vote

Key Management of Harmony Biosciences Holdings Inc

Name

Title

Mr. Christian Ulrich J.D.

General Counsel & Corporate Secretary

Ms. Tricia Glover

Chief Compliance Officer

Mr. Jeffrey S. Aronin

Founder & Non-Executive Chairman

Dr. Jeffrey M. Dayno M.D.

President, CEO & Director

Mr. Sandip S. Kapadia CPA, M.B.A.

Executive VP, Chief Administrative Officer & CFO

Dr. Kumar Budur M.D., M.S.

Executive VP and Chief Medical & Scientific Officer

Mr. Andrew Serafin J.D., M.B.A.

Executive VP & Chief Strategy Officer

Brennan Doyle

VP & Head of Investor Relations

Ms. Audrey Murphy SPHR

Chief Human Resources Officer

Ms. Cate McCanless

Senior VP & Chief Corporate Affairs Officer

FAQs

What is Harmony Biosciences Holdings Inc share price today?

Harmony Biosciences Holdings Inc share price today is $32.51 as on at the close of the market. Harmony Biosciences Holdings Inc share today touched a day high of $32.58 and a low of $31.61.

What is the 52 week high and 52 week low for Harmony Biosciences Holdings Inc share?

Harmony Biosciences Holdings Inc share touched a 52 week high of $41.61 on and a 52 week low of $26.47 on . Harmony Biosciences Holdings Inc stock price today i.e. is closed at $32.51,which is 21.87% down from its 52 week high and 22.82% up from its 52 week low.

What is Harmony Biosciences Holdings Inc's market capitalisation today?

Harmony Biosciences Holdings Inc market capitalisation is $0.00T as on .

How to invest in Harmony Biosciences Holdings Inc Stock (HRMY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Harmony Biosciences Holdings Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Harmony Biosciences Holdings Inc Shares that will get you 0.0461 shares as per Harmony Biosciences Holdings Inc share price of $32.51 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Harmony Biosciences Holdings Inc Stock (HRMY) from India?

Indian investors can start investing in Harmony Biosciences Holdings Inc (HRMY) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Harmony Biosciences Holdings Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Harmony Biosciences Holdings Inc share’s latest price of $32.51 as on September 16, 2025 at 1:29 am IST, you will get 0.3076 shares of Harmony Biosciences Holdings Inc. Learn more about fractional shares .

What are the returns that Harmony Biosciences Holdings Inc has given to Indian investors in the last 5 years?

Harmony Biosciences Holdings Inc stock has given -9.02% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?